Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Joseph P. Concannon"'
Autor:
Reuben Zemel, P. T. Narayanan Nambisan, Karl E. Blake, George A. Liebler, George J. Brodmerkel, Joseph P. Concannon
Publikováno v:
Annals of the New York Academy of Sciences. 276:97-105
Autor:
John C. Mitchell, George A. Liebler, Electra Markopoulos, Sheila E. Hodgson, William J. Cushing, Joseph P. Concannon, James J. Headings, Milton H. Dalbow
Publikováno v:
Cancer. 42:1477-1483
Preoperative plasma CEA levels were measured by radioimmunoassay for 149 patients with bronchogenic carcinoma. The data were used to determine the prognostic value of the CEA assay in these patients. The relationship of preoperative CEA levels with s
Autor:
Joseph P. Concannon, R. Perez-Tamayo, K. Stanley, Simon Kramer, H.G. Seydel, Philip Rubin, G. S. Brown, L. Brady, Carlos A. Perez, M. Rotman
Publikováno v:
Cancer. 45:2744-2753
Preliminary analysis is presented of a prospective randomized study involving 365 patients with histologically proven unresectable non-oat-cell carcinoma of the lung treated with definitive radiotherapy. The patients were randomized to one of four tr
Autor:
Karl Zimmerman, Sheila E. Hodgson, Karl E. Blake, Hassan Panahandeh, Joseph P. Concannon, George J. Brodmerkel, Milton H. Dalbow, James J. Headings
Publikováno v:
Diseases of the Colon & Rectum. 25:24-32
Preoperative levels of perchloric acid extractable plasma CEA were measured in 911 patients with complaints of the digestive system. A final diagnosis of benign disease was made for 579 patients; 332 patients were found to have cancer. Data for the p
Autor:
William F. Hanson, Carlos A. Perez, Joseph P. Concannon, G.Stephen Brown, Philip Rubin, Marvin Rotman, Simon Kramer, Graham Grundy, R. Perez-Tamayo, Luther W. Brady, Kenneth Stanley, James E. Marks
Publikováno v:
Cancer. 50:1091-1099
An analysis of intrathoracic tumor control was carried out in 378 patients with histologically proven unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy, randomized to one of four treatment regimens: 4000 rad split c
Autor:
Joseph P. Concannon, Milton H. Dalbow, T. H. M. Stewart, Hiroshi Takita, Ariel C. Hollinshead
Publikováno v:
Cancer. 60:1249-1262
The 10-year cumulative experiences of five year survivals of patients entered into a successful phase II specific active tumor-associated antigen (TAA) immunotherapy trial, a successful phase III specific active immunotherapy trial A and of patients
Autor:
William W. Davis, Joseph P. Concannon, Milton H. Dalbow, Sheila E. Hodgson, John C. Mitchell, Electra Markopoulos
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 4:255-261
Immunoprofile studies consisting of the measurement of de novo sensitization with DNCB, skin testing with microbial antigens, WBC and differential blood cell counts, enumeration of peripheral blood T and B lymphocytes and stimulation of lymphocytes w
Autor:
Joseph P. Concannon, George A. Liebler, Sheila E. Hodgson, George J. Magovern, Milton H. Dalbow
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 74:506-518
The general immune competence of 146 patients with bronchogenic carcinoma was measured, prior to irradiation therapy, by determining dinitrochlorobenzene (DNCB) reactivity, delayed cutaneous hypersensitivity (DCH) response to microbial antigens, peri
Publikováno v:
Radiology. 83:231-242
Accurate information regarding radiation distribution throughout the entire irradiated volume would be desirable for each patient treated with ionizing radiation from a teletherapy apparatus. Many therapy departments routinely prepare a complete isod